● Recruiting

Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

Condition: Adrenal Incidentalomas · Cushing Syndrome · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

PhasePhase 4

Planned participants50

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

Drug interventional, controlled, randomized open-label, parallel-group, multicenter study in patients with bilateral adrenal incidentalomas associated with subclinical Cushing's syndrome

This description comes directly from the study's public registry record.

Talk to the study team

Guido Di Dalmazi, MD · +390512143009 · guido.didalmazi@unibo.it

Always discuss trial participation with your own doctor first.

Locations (3)

IRCCS Azienda Ospedaliero-Universitaria di Bologna	Bologna, Italy	Recruiting
Azienda Ospedaliera Universitaria Federico II	Naples, Italy	Recruiting
Azienda Ospedale-Università Padova	Padova, Italy	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06801249